Article
Association between Human Blood Metabolome and the Risk of Alzheimer's Disease
28 Jul 2022
Abstract excerpt
Objective Alzheimer's disease (AD) is the most common degenerative neurological disorder with limited therapeutic options. Therefore, it is particularly important to explore the potential biomarkers implicated in the occurrence and progression of AD prior to clinical testing. Methods We selected 119 unique blood metabolites from 3 metabolome genome‐wide association studies (GWASs) with 147,827 European...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
